カテゴリ： GlobalData, アメリカ, 企業調査

Mayo Clinic：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Mayo Clinic - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7064
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：112
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. The organization also operates several colleges of medicine which offer various residency and fellowship programs. Its other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Mayo Clinic, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Mayo Clinic, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Mayo Clinic, Medical Equipment, Deal Details 16
Venture Financing 16
Vineti Raises USD33.5 million in Series B Venture Financing 16
Glooko Raises USD35 Million in Series C Financing 18
DayTwo Raises USD12 Million in Series A Financing 20
Vineti Raises USD13.75 Million in Series A Round of Financing 21
AliveCor Raises USD30 Million in Series D Financing 22
Chrono Therapeutics Raises USD47.6 Million in Series B Financing 23
AssureRx Health Raises Additional USD15 Million in Series D Financing 25
Welkin Health Raises USD2 Million in Seed Financing 26
Xcede Raises Additional USD1.4 Million in Venture Financing 27
Dicom Grid Raises USD6 Million in Venture Financing 28
AssureRx Health Raises USD7 Million in Venture Financing 29
Nevro Raises US$48 Million In Series C Financing 31
Omnis Pharma Raises Funds in Seed Financing 33
Axial Exchange Raises Funds Through Venture Financing 34
Partnerships 35
MediPines Enters into Licensing Agreement with Mayo Clinic 35
2bPrecise Enters into Licensing Agreement with Mayo Clinic 36
Titan Medical Enters into Licensing Agreement with Mayo Clinic 37
Advanced Biological Labs Enters into Licensing Agreement with Mayo Medical Labs 38
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 39
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 40
Amsel Medical Enters into Licensing Agreement with Mayo Clinic 41
Imbio Enters into Licensing Agreement with Mayo Clinic 42
Sanovas Enters Into Licensing Agreement With Mayo Clinic To Develop Technologies To Treat Asthma 43
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 44
Mayo Medical Labs Enters Into Licensing Agreement With A&G Pharma For Progranulin Blood Test 45
Baxter International and Mayo Clinic Form Renal Care Center 46
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 47
WuXi AppTec and Mayo Clinic Form Joint Venture 48
AliveCor Enters into Agreement with Mayo Clinic 49
Medibio Enters into Agreement with Mayo Clinic 50
MRI Interventions Enters into Co-Development Agreement with Mayo Clinic 51
Illumina Enters into Agreement with Mayo Clinic 52
ImpediMed Enters into Co-Development Agreement with Mayo Clinic 53
Transplant Genomics Enters into Agreement with Mayo Clinic Center for Individualized Medicine 54
ImpediMed Enters into Agreement with Mayo Clinic 55
Zora Biosciences Enters into Agreement with Mayo Medical 56
GE Ventures Forms Joint Venture with Mayo Clinic 57
Boston Scientific Partners with Mayo Clinic 58
Neuro Assessment Systems Enters into Agreement with Mayo Clinic 59
Minnesota Medical Technologies Enters into R&D Agreement with Mayo Clinic 60
Gentag, Mayo Clinic, NovioSense and Fraunhofer IMS Form Joint Venture 61
Mayo Clinic Enters into Co-Development Agreement with Gentag 62
Leica Biosystems Nussloch Partners with Mayo Clinic 63
GenomeDx Expands Research Agreement with Mayo Clinic 64
Enterome Enters into Co-Development Agreement with Mayo Clinic 65
Mayo Clinic Center for Individualized Medicine Enters into Co-Development Agreement with Whole Biome 66
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 67
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 68
MedidaMetrics Enters Into Co-Development Agreement With Mayo Clinic 69
Mayo Clinic Enters Into Co-Development Agreement With Dynasil 70
SoftGenetics Enters Into Co-Development Agreement With Mayo Clinic 71
Mayo Clinic Enters into Licensing Agreement with King-Devick Test for Sideline Concussion Testing 72
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 73
Acquisition 74
Axial Exchange Acquires mRemedy From Mayo Clinic And DoApp 74
Mayo Clinic – Key Competitors 75
Mayo Clinic – Key Employees 76
Mayo Clinic – Locations And Subsidiaries 77
Head Office 77
Other Locations & Subsidiaries 77
Joint Venture 78
Recent Developments 80
Corporate Communications 80
May 08, 2018: Mayo Clinic opioid expert appointed to serve on new pain management task force 80
Government and Public Interest 81
Jun 20, 2018: Mayo researchers identify method to diagnose pancreatic cancer in patients with early onset diabetes 81
Jul 11, 2017: Prosthetic knee type may determine cost of care for amputees 82
Product News 84
Oct 01, 2018: Mayo researchers develop new genetics-based prognostic tool for myelodysplastic syndrome 84
Oct 01, 2018: New Mayo Clinic GeneGuide DNA testing application provides genetic testing insights backed by Mayo Clinic expertise 85
Sep 24, 2018: Spinal cord stimulation physical therapy help paralyzed man stand walk with assistance 87
Aug 21, 2018: Engineers develop A.I. system to detect often-missed cancer tumors 89
Aug 07, 2018: Mayo-led research team identifies genes that increase risk for triple-negative breast cancer 90
Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 91
May 24, 2018: New method to thwart false positives in CT-lung cancer screening 92
May 15, 2018: Researchers identify method to overcome false positives in CT imaging for lung cancer 93
Mar 24, 2018: Genetic testing to enhance multiple myeloma treatment 94
Feb 05, 2018: Children’s Hospital Los Angeles Joins National Consortium to Study Use of Stem Cells in Treating a Rare Cardiac Defect 95
Jan 02, 2018: Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities 96
Dec 14, 2017: Mayo Clinic to begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities 97
Oct 30, 2017: NAPT Calls Attention To Promising Clinical Trial Results Presented At Particle Therapy Cooperative Group Meeting In Chicago 98
Jun 29, 2017: Study Used Iso-Seq Method to Unravel Activity of Receptors in Prostate Cancer 99
Apr 19, 2017: Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy 100
Other Significant Developments 101
Sep 11, 2018: MyCare becomes Recognized Referral Facilitator for Mayo Clinic 101
May 22, 2018: Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk 102
May 10, 2018: Previously Invisible Long QT Syndrome Now Observable With Machine Learning 103
May 07, 2018: Mayo Clinic implements Epic electronic health record at its Rochester campus 104
Feb 09, 2018: New CT scanner being installed in Albert Lea 105
Dec 07, 2017: Mayo Clinic study finds emojis promising tool for tracking cancer patients’ quality of life 106
Nov 30, 2017: ASU adds diversity to $8.6 million Mayo Clinic-led network for patient-centered research 107
Oct 26, 2017: Team to develop steerable robotic needle for biopsies 109
Feb 28, 2017: Respiri’s Text and App Messaging for Better Asthma Care 110
Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner 111
Appendix 112
Methodology 112
About GlobalData 112
Contact Us 112
Disclaimer 112

List of Tables
Mayo Clinic, Medical Equipment, Key Facts, 2017 2
Mayo Clinic, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Mayo Clinic, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Mayo Clinic, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Deals By Market, 2012 to YTD 2018 11
Mayo Clinic, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Vineti Raises USD33.5 million in Series B Venture Financing 16
Glooko Raises USD35 Million in Series C Financing 18
DayTwo Raises USD12 Million in Series A Financing 20
Vineti Raises USD13.75 Million in Series A Round of Financing 21
AliveCor Raises USD30 Million in Series D Financing 22
Chrono Therapeutics Raises USD47.6 Million in Series B Financing 23
AssureRx Health Raises Additional USD15 Million in Series D Financing 25
Welkin Health Raises USD2 Million in Seed Financing 26
Xcede Raises Additional USD1.4 Million in Venture Financing 27
Dicom Grid Raises USD6 Million in Venture Financing 28
AssureRx Health Raises USD7 Million in Venture Financing 29
Nevro Raises US$48 Million In Series C Financing 31
Omnis Pharma Raises Funds in Seed Financing 33
Axial Exchange Raises Funds Through Venture Financing 34
MediPines Enters into Licensing Agreement with Mayo Clinic 35
2bPrecise Enters into Licensing Agreement with Mayo Clinic 36
Titan Medical Enters into Licensing Agreement with Mayo Clinic 37
Advanced Biological Labs Enters into Licensing Agreement with Mayo Medical Labs 38
Inform Bioscience Enters into Licensing Agreement with Mayo Clinic 39
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 40
Amsel Medical Enters into Licensing Agreement with Mayo Clinic 41
Imbio Enters into Licensing Agreement with Mayo Clinic 42
Sanovas Enters Into Licensing Agreement With Mayo Clinic To Develop Technologies To Treat Asthma 43
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 44
Mayo Medical Labs Enters Into Licensing Agreement With A&G Pharma For Progranulin Blood Test 45
Baxter International and Mayo Clinic Form Renal Care Center 46
SkylineDx Enters into Co-Development Agreement with Mayo Clinic 47
WuXi AppTec and Mayo Clinic Form Joint Venture 48
AliveCor Enters into Agreement with Mayo Clinic 49
Medibio Enters into Agreement with Mayo Clinic 50
MRI Interventions Enters into Co-Development Agreement with Mayo Clinic 51
Illumina Enters into Agreement with Mayo Clinic 52
ImpediMed Enters into Co-Development Agreement with Mayo Clinic 53
Transplant Genomics Enters into Agreement with Mayo Clinic Center for Individualized Medicine 54
ImpediMed Enters into Agreement with Mayo Clinic 55
Zora Biosciences Enters into Agreement with Mayo Medical 56
GE Ventures Forms Joint Venture with Mayo Clinic 57
Boston Scientific Partners with Mayo Clinic 58
Neuro Assessment Systems Enters into Agreement with Mayo Clinic 59
Minnesota Medical Technologies Enters into R&D Agreement with Mayo Clinic 60
Gentag, Mayo Clinic, NovioSense and Fraunhofer IMS Form Joint Venture 61
Mayo Clinic Enters into Co-Development Agreement with Gentag 62
Leica Biosystems Nussloch Partners with Mayo Clinic 63
GenomeDx Expands Research Agreement with Mayo Clinic 64
Enterome Enters into Co-Development Agreement with Mayo Clinic 65
Mayo Clinic Center for Individualized Medicine Enters into Co-Development Agreement with Whole Biome 66
Mayo Clinic Enters Into Co-Development Agreement With Banner Health For Diagnostic Tests 67
Silicon Valley Biosystems Enters Into Agreement With Mayo Clinic For Genome Diagnostics 68
MedidaMetrics Enters Into Co-Development Agreement With Mayo Clinic 69
Mayo Clinic Enters Into Co-Development Agreement With Dynasil 70
SoftGenetics Enters Into Co-Development Agreement With Mayo Clinic 71
Mayo Clinic Enters into Licensing Agreement with King-Devick Test for Sideline Concussion Testing 72
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 73
Axial Exchange Acquires mRemedy From Mayo Clinic And DoApp 74
Mayo Clinic, Key Competitors 75
Mayo Clinic, Key Employees 76
Mayo Clinic, Other Locations 77
Mayo Clinic, Subsidiaries 77
Mayo Clinic, Joint Venture 78

List of Figures
Mayo Clinic, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Mayo Clinic, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Mayo Clinic, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Mayo Clinic, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Mayo Clinic, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Mayo Clinic, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Mayo Clinic, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Mayo Clinic, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Mayo Clinic：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ansell Limited：企業の戦略・SWOT・財務情報
    Ansell Limited - Strategy, SWOT and Corporate Finance Report Summary Ansell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Manali Petrochemicals Ltd (MANALIPETC)：企業の財務・戦略的SWOT分析
    Summary Manali Petrochemicals Ltd (MPL), a subsidiary of Southern Petrochemical Industries Corp Ltd, is a chemical company that develops and markets petrochemical products. The company offers products such as propylene oxide, propylene glycol, flexible and molded polyols, rigid polyols and elastomer …
  • Golden Spread Electric Cooperative Inc：企業の戦略的SWOT分析
    Golden Spread Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • New Image Group Ltd：企業の戦略的SWOT分析
    New Image Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd：企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • ASC Pty Ltd：企業の戦略・SWOT・財務情報
    ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hitachi Chemical Co Ltd (4217)：企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Magellan Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary Magellan Diagnostics Inc (Magellan Diagnostics), formerly ESA Inc, a subsidiary of Meridian Bioscience Inc, is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services. The company’s products include LeadCare II, LeadCa …
  • University of Michigan：企業のM&A・事業提携・投資動向
    University of Michigan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Michigan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • NTT DOCOMO, Inc.：企業の戦略・SWOT・財務情報
    NTT DOCOMO, Inc. - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Smithfield Foods Inc：戦略・SWOT・企業財務分析
    Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Magnitogorsk Metallurgicheskiy Kombinat：企業の戦略・SWOT・財務情報
    Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Metallurgicheskiy Kombinat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Orchard Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Orchard Therapeutics Ltd (Orchard) is an integrated commercial-stage biotechnology company that develops gene therapies for the treatment of serious and life-threatening orphan diseases. Its pipeline products include Strimvelis, an autologous ex vivo gammaretroviral gene therapy for the trea …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野：企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Chesswood Group Ltd (CHW)：企業の財務・戦略的SWOT分析
    Chesswood Group Ltd (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Akita Bank Ltd：企業の戦略・SWOT・財務情報
    The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Impol Seval A.D. Sevojno：企業の戦略・SWOT・財務分析
    Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report Summary Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sinopec Oilfield Service Corp (600871)：企業の財務・戦略的SWOT分析
    Sinopec Oilfield Service Corp (600871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Diffusion Pharmaceuticals Inc (DFFN)：企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • New World Development Company Limited：企業の戦略・SWOT・財務情報
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆